• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Trishistidine Pseudopeptide with Ability to Remove Both Cu and Cu from the Amyloid-β Peptide and to Stop the Associated ROS Formation.一种含组氨酸三肽的假肽,能够从淀粉样β肽中同时去除 Cu 和 Cu,并阻止相关的 ROS 形成。
Chemistry. 2017 Dec 1;23(67):17078-17088. doi: 10.1002/chem.201703429. Epub 2017 Nov 9.
2
Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.基于双组氨酸菲咯啉的杂化配体减轻 Aβ 结合 Cu 的 ROS 生成:Cu(I)重要性的例证。
Molecules. 2021 Dec 16;26(24):7630. doi: 10.3390/molecules26247630.
3
The amyloid-beta peptide of Alzheimer's disease binds Cu(I) in a linear bis-his coordination environment: insight into a possible neuroprotective mechanism for the amyloid-beta peptide.阿尔茨海默病的β-淀粉样肽在一个线性双组氨酸配位环境中结合Cu(I):对β-淀粉样肽可能的神经保护机制的深入了解。
J Am Chem Soc. 2008 Dec 31;130(52):17826-35. doi: 10.1021/ja805940m.
4
Rationally Designed Cu(I) Ligand to Prevent CuAβ-Generated ROS Production in the Alzheimer's Disease Context.理性设计的 Cu(I) 配体可预防阿尔茨海默病中 CuAβ 产生的 ROS。
Inorg Chem. 2024 Feb 5;63(5):2340-2351. doi: 10.1021/acs.inorgchem.3c02693. Epub 2024 Jan 20.
5
An integrated study of the affinities of the Aβ16 peptide for Cu(I) and Cu(II): implications for the catalytic production of reactive oxygen species.Aβ16肽与Cu(I)和Cu(II)亲和力的综合研究:对活性氧催化产生的影响。
Metallomics. 2014 Mar;6(3):505-17. doi: 10.1039/c4mt00001c. Epub 2014 Feb 3.
6
Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps.意想不到的 Aβ 肽中铜去除趋势:配体越少越好,锌有帮助。
Inorg Chem. 2021 Jan 18;60(2):1248-1256. doi: 10.1021/acs.inorgchem.0c03407. Epub 2021 Jan 5.
7
Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.甲硫氨酸不会还原Cu(II)-β-淀粉样蛋白!——甲硫氨酸-35和还原剂在Cu(II)-β-淀粉样蛋白的金属中心氧化化学中的作用修正
Biochim Biophys Acta. 2009 Jan;1792(1):49-55. doi: 10.1016/j.bbadis.2008.11.004. Epub 2008 Nov 13.
8
X-ray Absorption Spectroscopy Investigations of Copper(II) Coordination in the Human Amyloid β Peptide.X 射线吸收光谱研究人淀粉样β肽中铜(II)的配位
Inorg Chem. 2019 May 6;58(9):6294-6311. doi: 10.1021/acs.inorgchem.9b00507. Epub 2019 Apr 23.
9
Ability of Azathiacyclen Ligands To Stop Cu(Aβ)-Induced Production of Reactive Oxygen Species: [3N1S] Is the Right Donor Set.氮杂环壬烷配体阻止铜(β-淀粉样蛋白)诱导产生活性氧的能力:[3N1S]是合适的供体组合。
Chemistry. 2023 Mar 7;29(14):e202203667. doi: 10.1002/chem.202203667. Epub 2023 Jan 26.
10
Reaction rates and mechanism of the ascorbic acid oxidation by molecular oxygen facilitated by Cu(II)-containing amyloid-beta complexes and aggregates.含铜(II)淀粉样β复合物和聚集体促进的抗坏血酸氧化的反应速率和机制。
J Phys Chem B. 2010 Apr 15;114(14):4896-903. doi: 10.1021/jp9095375.

引用本文的文献

1
Novel Copper Chelators Enhance Spatial Memory and Biochemical Outcomes in Alzheimer's Disease Model.新型铜螯合剂可改善阿尔茨海默病模型的空间记忆及生化指标。
ACS Chem Neurosci. 2025 Sep 3;16(17):3267-3281. doi: 10.1021/acschemneuro.5c00291. Epub 2025 Aug 15.
2
Peptide-based amyloid-beta aggregation inhibitors.基于肽的β-淀粉样蛋白聚集抑制剂。
RSC Med Chem. 2024 Dec 31. doi: 10.1039/d4md00729h.
3
Biomimetic Pseudopeptides to Decipher the Interplay between Cu and Methionine-Rich Domains in Proteins.用于解析蛋白质中铜与富含甲硫氨酸结构域之间相互作用的仿生假肽
Chemistry. 2025 Feb 20;31(11):e202403896. doi: 10.1002/chem.202403896. Epub 2025 Jan 9.
4
Why the Ala-His-His Peptide Is an Appropriate Scaffold to Remove and Redox Silence Copper Ions from the Alzheimer's-Related Aβ Peptide.为什么 Ala-His-His 肽是从阿尔茨海默病相关 Aβ肽中去除和还原沉默铜离子的合适支架。
Biomolecules. 2022 Sep 20;12(10):1327. doi: 10.3390/biom12101327.
5
Hybrid Bis-Histidine Phenanthroline-Based Ligands to Lessen Aβ-Bound Cu ROS Production: An Illustration of Cu(I) Significance.基于双组氨酸菲咯啉的杂化配体减轻 Aβ 结合 Cu 的 ROS 生成:Cu(I)重要性的例证。
Molecules. 2021 Dec 16;26(24):7630. doi: 10.3390/molecules26247630.
6
Crystal structure of -poly[[[di-chlorido-copper(II)]-{μ--butyl -methyl--[4-(6-{[4-(pyridin-2-yl-κ)-1-1,2,3-triazol-1-yl-κ]meth-yl}-1,3-benzo-thia-zol-2-yl)phen-yl]carbamato}] aceto-nitrile monosolvate].-聚[[[二氯合铜(II)]-{μ-丁基-甲基-4-[6-{[4-(吡啶-2-基-κ)-1,2,3-三唑-1-基-κ]甲基}-1,3-苯并噻唑-2-基]苯基]氨基甲酸酯}]乙腈单溶剂合物的晶体结构
Acta Crystallogr E Crystallogr Commun. 2018 Jan 12;74(Pt 2):158-162. doi: 10.1107/S2056989018000488. eCollection 2018 Feb 1.
7
A Metallo Pro-Drug to Target Cu in the Context of Alzheimer's Disease.针对阿尔茨海默病中 Cu 的金属前药。
Chemistry. 2018 Apr 6;24(20):5095-5099. doi: 10.1002/chem.201706049. Epub 2018 Feb 16.

本文引用的文献

1
Identification of key structural features of the elusive Cu-Aβ complex that generates ROS in Alzheimer's disease.确定在阿尔茨海默病中产生活性氧的难以捉摸的铜-淀粉样β蛋白复合物的关键结构特征。
Chem Sci. 2017 Jul 1;8(7):5107-5118. doi: 10.1039/c7sc00809k. Epub 2017 May 4.
2
The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.放弃阿尔茨海默病中铜离子治疗性螯合的理由。
Front Neurosci. 2017 Jun 2;11:317. doi: 10.3389/fnins.2017.00317. eCollection 2017.
3
Fluorescent Copper Probe Inhibiting Aβ1-16-Copper(II)-Catalyzed Intracellular Reactive Oxygen Species Production.抑制Aβ1-16-铜(II)催化的细胞内活性氧生成的荧光铜探针
Inorg Chem. 2017 Apr 3;56(7):3729-3732. doi: 10.1021/acs.inorgchem.6b02915. Epub 2017 Mar 20.
4
Link between Affinity and Cu(II) Binding Sites to Amyloid-β Peptides Evaluated by a New Water-Soluble UV-Visible Ratiometric Dye with a Moderate Cu(II) Affinity.新型水溶性紫外-可见比率荧光染料,具有适度的 Cu(II) 亲和力,用于评估与淀粉样β肽的亲和力和 Cu(II) 结合位点之间的关系。
Anal Chem. 2017 Feb 7;89(3):2155-2162. doi: 10.1021/acs.analchem.6b04979. Epub 2017 Jan 25.
5
Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments.金属与淀粉样前体蛋白及其蛋白水解片段结合的结构与突触功能
Front Mol Neurosci. 2017 Jan 31;10:21. doi: 10.3389/fnmol.2017.00021. eCollection 2017.
6
Cyclic Phosphopeptides to Rationalize the Role of Phosphoamino Acids in Uranyl Binding to Biological Targets.环状磷酸肽可合理阐明磷酸氨基酸在铀酰与生物靶标结合中的作用。
Chemistry. 2017 Apr 19;23(22):5281-5290. doi: 10.1002/chem.201605481. Epub 2017 Mar 29.
7
Numerical Simulations Reveal Randomness of Cu(II) Induced Aβ Peptide Dimerization under Conditions Present in Glutamatergic Synapses.数值模拟揭示了在谷氨酸能突触存在的条件下铜(II)诱导Aβ肽二聚化的随机性。
PLoS One. 2017 Jan 26;12(1):e0170749. doi: 10.1371/journal.pone.0170749. eCollection 2017.
8
Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends.治疗阿尔茨海默病的临床试验药物:主要趋势。
Med Res Rev. 2017 Sep;37(5):1186-1225. doi: 10.1002/med.21434. Epub 2017 Jan 13.
9
How Zn can impede Cu detoxification by chelating agents in Alzheimer's disease: a proof-of-concept study.锌如何在阿尔茨海默病中通过螯合剂阻碍铜解毒:一项概念验证研究。
Dalton Trans. 2016 Oct 4;45(39):15671-15678. doi: 10.1039/c6dt02308h.
10
Tripeptide GGH as the Inhibitor of Copper-Amyloid-β-Mediated Redox Reaction and Toxicity.三肽 GGH 作为铜-淀粉样β介导的氧化还原反应和毒性的抑制剂。
ACS Chem Neurosci. 2016 Sep 21;7(9):1255-63. doi: 10.1021/acschemneuro.6b00145. Epub 2016 Aug 3.

一种含组氨酸三肽的假肽,能够从淀粉样β肽中同时去除 Cu 和 Cu,并阻止相关的 ROS 形成。

A Trishistidine Pseudopeptide with Ability to Remove Both Cu and Cu from the Amyloid-β Peptide and to Stop the Associated ROS Formation.

机构信息

CNRS, LCC, Laboratoire de Chimie de Coordination, 205 route de Narbonne, BP 44099, 31077, Toulouse Cedex 4, France.

University of Toulouse, UPS, INPT, 31077, Toulouse Cedex 4, France.

出版信息

Chemistry. 2017 Dec 1;23(67):17078-17088. doi: 10.1002/chem.201703429. Epub 2017 Nov 9.

DOI:10.1002/chem.201703429
PMID:28846165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5714062/
Abstract

The pseudopeptide L, derived from a nitrilotriacetic acid scaffold and functionalized with three histidine moieties, is reminiscent of the amino acid side chains encountered in the Alzheimer's peptide (Aβ). Its synthesis and coordination properties for Cu and Cu are described. L efficiently complex Cu in a square-planar geometry involving three imidazole nitrogen atoms and an amidate-Cu bond. By contrast, Cu is coordinated in a tetrahedral environment. The redox behavior is irreversible and follows an ECEC mechanism in accordance with the very different environments of the two redox states of the Cu center. This is in line with the observed resistance of the Cu complex to oxidation by oxygen and the Cu complex reduction by ascorbate. The affinities of L for Cu and Cu at physiological pH are larger than that reported for the Aβ peptide. Therefore, due to its peculiar Cu coordination properties, the ligand L is able to target both redox states of Cu, redox silence them and prevent reactive oxygen species production by the CuAβ complex. Because reactive oxygen species contribute to the oxidative stress, a key issue in Alzheimer's disease, this ligand thus represents a new strategy in the long route of finding molecular concepts for fighting Alzheimer's disease.

摘要

由三部分组成的假肽 L 是从三乙撑四胺乙酸骨架衍生而来,其中有三个组氨酸残基,这让人联想到阿尔茨海默病肽(Aβ)中的氨基酸侧链。本文描述了其合成及其与 Cu 和 Cu 的配位性质。L 能够以平面四方几何构型高效地与 Cu 配位,其中三个咪唑氮原子和一个酰胺-Cu 键参与配位。相比之下,Cu 以四面体型环境配位。氧化还原行为是不可逆的,遵循 ECEC 机制,这与 Cu 中心两种氧化还原态的环境非常不同。这与观察到的 Cu 配合物不易被氧气氧化和 Cu 配合物被抗坏血酸还原的现象一致。在生理 pH 值下,L 对 Cu 和 Cu 的亲和力大于 Aβ 肽的报道值。因此,由于其独特的 Cu 配位性质,配体 L 能够靶向 Cu 的两种氧化还原态,使其沉默,并防止 CuAβ 配合物产生活性氧物种。由于活性氧物种会导致氧化应激,这是阿尔茨海默病的一个关键问题,因此,这种配体代表了在寻找治疗阿尔茨海默病的分子概念的漫长道路上的一种新策略。